Thurs., 10/18/07 Polytrauma, Paper #7, 2:15 pm OTA-2007
Saam Morshed, MD, MPH (n); Luis A. Corrales, BS (n); Cindy H. Lin, BS, MPH (n);
Theodore Miclau, MD (n);
Department of Orthopaedic Surgery, San Francisco General Hospital,
University of California, San Francisco School of Medicine, San Francisco, California, USA
Thurs., 10/18/07 Polytrauma, Paper #8, 2:21 pm OTA-2007
Hans-Christoph Pape, MD1 (n); Dieter Rixen, MD2 (n); Elisabeth Ellingsen Husbye, MD3 (n); Michael Mueller, MD4 (n); Clemens Dumont, MD5 (n); Christian Krettek, MD6 (n);
Peter Giannoudis, MD7 (n); Peter Epoff, MD8 (n);
1University of Pittsburgh, Pittsburgh, Pennsylvania, USA;
2University of Witten Herdecke, Witten, North Rhine-Westphalia, Germany;
3University of Oslo, Oslo, Norway;
4University of Kiel, Kiel, Germany;
5University of Göttingen, Göttingen, Germany;
6University of Hannover, Hannover, Germany;
7University of Leeds, Leeds, United Kingdom;
8Olso, Kiel, Rosenheim, Marburg
Thurs., 10/18/07 Polytrauma, Paper #9, 2:27 pm OTA-2007
Christopher Tzioupis, MD1 (n); Ivan Tarkin, MD1 (n); Philipp Kobbe, MD1 (n);
Mohamad K. Allami, MD3 (n); Kirsten Sommer, MD2 (n); Martin van Griensven, MD3 (n); Christian Krettek, MD2 (n); Peter V. Giannoudis, MD4 (n); Hans-Christoph Pape, MD1 (n);
1Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA;
2Department of Trauma Surgery, Hannover Medical School, Hannover, Germany;
3Ludwig Boltzmann Institute for Experimental Surgery, Vienna, Austria;
4Department of Trauma Surgery, St. James’s University Hospital, Leeds, United Kingdom
Thurs., 10/18/07 Polytrauma, Paper #10, 2:40 pm OTA-2007
Long-Term Outcome Assessment after Trauma: Does Gender Play a Role?
Christian Probst, MD1 (n); Boris Zelle, MD2 (n); Martin Panzica, MD1 (n);
Ralf Lohse, MD3 (n); Nicola Alexander Sitarro, MD3 (n); Christian Krettek, MD1 (n);
Hans-Christoph Pape, MD2 (n);
1Department of Trauma, Hannover Medical School, Hannover, Germany;
2Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA;
3Hannover Re Insurances, Hannover, Germany
Thurs., 10/18/07 Polytrauma, Paper #11, 2:46 pm OTA-2007
Keith M. Willett, FRCS1 (n); H. Al-Khateeb, MD1 (n); Rohit Kotnis, MD1 (n);
Omar Bouamra2 (n); Fiona Lecky, PhD2 (n);
1Trauma Unit, John Radcliffe Hospital, Oxford, United Kingdom;
2Trauma Audit Research Network, University of Manchester, United Kingdom
Thurs., 10/18/07 Polytrauma, Paper #12, 2:59 pm OTA-2007
Negative-Pressure Wound Therapy following High-Risk Lower Extremity Fractures
James P. Stannard, MD1 (a-Kinetic Concepts, Inc.); David A. Volgas, MD1 (n);
Gerald McGwin III, PhD1 (n); Rena L. Stewart, MD1 (n);
William T. Obremskey, MD2 (a-Kinetic Concepts, Inc.);
Thomas Moore, MD3 (a-Kinetic Concepts, Inc.);
Jeffrey O. Anglen, MD4 (a-Kinetic Concepts, Inc.);
1University of Alabama at Birmingham, Birmingham, Alabama, USA;
2Vanderbilt University, Nashville, Tennessee, USA;
3Emory Healthcare, Atlanta, Georgia, USA;
4Wishard Health Services, Indianapolis, Indiana, USA
Thurs., 10/18/07 Polytrauma, Paper #13, 3:05 pm OTA-2007
Patrick M. Osborn, CAPT, MC USAF (n); Wade R. Smith, MD (n); C. Clay Cothren, MD (n); Steven J. Morgan, MD (n); Allison R. Williams, PhD (n); Philip F. Stahel, MD (n);
Ernest E. Moore, MD (n);
Denver Health Medical Center, Denver, Colorado, USA
Thurs., 10/18/07 Polytrauma, Paper #14, 3:11 pm OTA-2007
CT Angiography for Pelvic Trauma Predicts Angiographically Treatable Arterial Bleeding
Jodi Siegel, MD (n); Paul Tornetta III, MD (n); Peter Burke, MD (n); Neema Kaseje, MD (n); Suresh Agarwal, MD (n); Jorge Soto, MD (n); Stephan Anderson (n);
Boston University Medical Center, Boston, Massachusetts, USA
If noted, the author indicates something of value received. The codes are identified as a-research or institutional support; b-miscellaneous funding; c-royalties; d-stock options; e-consultant or employee; n-no conflicts disclosed, and *disclosure not available at time of printing.
• The FDA has not cleared this drug and/or medical device for the use described in this presentation (i.e., the drug or medical device is being discussed for an “off label” use). ◆FDA information not available at time of printing.